Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
FDA
Sep 14, 2024, 14:02 |
Blog
Amol Akhade: Advanced cell therapy for solid tumors - Where do we stand?
Amol Akhade posted the following on LinkedIn: “I don’t know who should know this more…
Sep 14, 2024, 13:51 |
Blog
Tatiana Prowell: I was a doctor before the Affordable Care Act
Monica Verduzco-Gutierrez, Professor and Chair of Rehabilitation Medicine at the Long School of Medicine at…
Sep 14, 2024, 00:00 |
Insight
Komal Jhaveri: The triplet with fulvestrant backbone yielded a mPFS of 35 months in HER2-negative breast cancer
Komal Jhaveri, Patricia and James Cayne Chair for Junior Faculty, Associate Member, Breast Medicine and…
Sep 13, 2024, 19:19 |
Blog
Advances in cancer care must consider the impact on patients’ reproductive health - ASCO
ASCO - American Society of Clinical Oncology made the following post on LinkedIn: “Advances in cancer care…
Sep 13, 2024, 19:00 |
Blog
Brian Shields discusses TROPION-Lung01 Clinical Trial and AI’s role in content curation
Brian Shields, Creator of KOL Pulse AI, posted the following on LinkedIn: “One of the…
Sep 13, 2024, 14:15 |
Opinion
Emma Moran: Launching the CobiCure Fellowship for Pediatric MedTech Innovation
Emma Moran shared on LinkedIn: "We are thrilled to announce the launch of the CobiCure…
Sep 13, 2024, 12:55 |
Blog
Shubh G: NeoCOAST and AEGEAN trial results at WCLC
Shubh G, VP, US Franchise Head, Immuno-Oncology and GI Tumors at AstraZeneca, shared a post…
Sep 12, 2024, 11:01 |
Societies
2024 IASLC Distinguished Service Awards Recipients
The IASLC Distinguished Service Awards recognize the "luminaries" in the field of lung and thoracic cancers- those…
Sep 12, 2024, 09:24 |
Societies
Marianne Sarcich: Dense breast tissue is a breast cancer risk
Marianne Sarcich, Founder of Breast Health 101 with Marianne, shared on LinkedIn: "Now, when you get…
Sep 11, 2024, 16:13 |
Insight
RYBREVANT plus LAZCLUZE versus osimertinib in EGFR-mutated advanced lung cancer
New longer-term data from the MARIPOSA study confirm superior outcomes of chemotherapy-free RYBREVANT plus LAZCLUZE regimen compared…
30
31
32
33
34
All:
946
Posts:
311 - 320
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube